Physician profile
Mary Olender
NPI 1922199504
$2,308.80
in general payments reported to CMS, 2019-2025
27 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $303 · 2021: $547 · 2022: $476 · 2023: $236 · 2024: $212 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $843.96 | 2019-2023 | |
| Pfizer INC. | $443.77 | 2020-2025 | |
| Mayne Pharma Commercial LLC | $195.64 | 2022-2025 | |
| Organon LLC | $88.51 | 2024-2025 | Nexplanon |
| Allergan, INC. | $79.20 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $70.18 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $67.78 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.19 | 2019 | |
| Duchesnay USA Incorporated | $40.01 | 2019 | |
| Sage Therapeutics, LLC | $39.63 | 2024 | |
| Exeltis, USA INC. | $35.92 | 2019-2024 | Slynd |
| Bausch Health US, LLC | $33.61 | 2021 | |
| Astellas Pharma US INC | $33.08 | 2023 | Veozah |
| Agile Therapeutics, INC. | $31.75 | 2023-2024 | Twirla |
| Scynexis, INC. | $28.51 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $27.48 | 2024 | |
| Therapeuticsmd, INC. | $24.20 | 2022 | |
| Novo Nordisk INC | $22.23 | 2022 | |
| Merck Sharp & Dohme LLC | $22.13 | 2021 | |
| Roche Diagnostics Corporation | $21.46 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $20.27 | 2023 | Vivjoa |
| Hologic Sales and Service, LLC | $20.27 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.96 | 2019 | |
| Lupin INC. | $14.74 | 2019 | |
| Evofem Biosciences, INC. | $14.40 | 2022 | |
| Zyla Life Sciences, INC. | $14.20 | 2020 | |
| Aspira Women'S Health INC | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Olender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.